Vitamin D Regulation of Immune Function

Vitamins and Hormones

Volumn 86, Issue , 2011, Pages 1-21

  Bikle, Daniel D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptive immunity; Autoimmune disease; Cathelicidin; Infection; Innate immunity; Keratinocyte; Macrophage; Vitamin D

Indexed keywords

VITAMIN D;

ADAPTIVE IMMUNITY; ANIMAL; AUTOIMMUNITY; BOOK; HUMAN; IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAMIN D DEFICIENCY;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNITY; HUMANS; IMMUNITY; IMMUNITY, INNATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79952646506     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386960-9.00001-0     Document Type: Book

References (88)

1. Adamopoulos I.E., Bowman E.P. Immune regulation of bone loss by Th17 cells. Arthritis Res. Ther. 2008, 10:225.
2. Adorini L. Intervention in autoimmunity: The potential of vitamin D receptor agonists. Cell. Immunol. 2005, 233:115-124.
3. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 2008, 4:404-412.
4. Andersson S., Davis D.L., Dahlbäck H., Jörnvall H., Russell D.W. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 1989, 264:8222-8229.
5. Armbrecht H.J., Forte L.R., Wongsurawat N., Zenser T.V., Davis B.B. Forskolin increases 1,25-dihydroxyvitamin D3 production by rat renal slices in vitro. Endocrinology 1984, 114:644-649.
6. Ascherio A., Munger K.L., Simon K.C. Vitamin D and multiple sclerosis. Lancet Neurol. 2010, 9:599-612.
7. Back O., Blomquist H.K., Hernell O., Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy?. Acta Derm. Venereol. 2009, 89:28-32.
8. Baroni E., Biffi M., Benigni F., Monno A., Carlucci D., Carmeliet G., Bouillon R., D'Ambrosio D. VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 2007, 81:250-262.
9. Berginer V.M., Shany S., Alkalay D., Berginer J., Dekel S., Salen G., Tint G.S., Gazit D. Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 1993, 42:69-74.
10. Bikle D.D. Nonclassical actions of vitamin D. J. Endocrinol. Metab. 2009, 94:26-34.
11. Bikle D. Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications. Vitamin D: Physiology, Molecular Biology, and Clinical Applications 2010, 277-295. Humana Press, New York. M. Holick (Ed.).
12. Bikle D.D., Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocr. Rev. 1993, 14:3-19.
13. Bikle D.D., Pillai S., Gee E., Hincenbergs M. Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 1989, 124:655-660.
14. Bikle D.D., Pillai S., Gee E., Hincenbergs M. Tumor necrosis factor-alpha regulation of 1,25-dihydroxyvitamin D production by human keratinocytes. Endocrinology 1991, 129:33-38.
15. Bitetto D., Fabris C., Falleti E., Fornasiere E., Fumolo E., Fontanini E., Cussigh A., Occhino G., Baccarani U., Pirisi M., Toniutto P. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int. 2010, 30:417-444.
16. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., Demay M. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776.
17. Brehm J.M., Schuemann B., Fuhlbrigge A.L., Hollis B.W., Strunk R.C., Zeiger R.S., Weiss S.T., Litonjua A.A. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol. 2010, 126:52-58.
18. Brenza H.L., Kimmel-Jehan C., Jehan F., Shinki T., Wakino S., Anazawa H., Suda T., DeLuca H.F. Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc. Natl. Acad. Sci. USA 1998, 95:1387-1391.
19. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285:732-736.
20. Cali J.J., Russell D.W. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J. Biol. Chem. 1991, 266:7774-7778.
21. Cali J.J., Hsieh C.L., Francke U., Russell D.W. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 1991, 266:7779-7783.
22. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 2007, 179:1634-1647.
23. Cheng J.B., Motola D.L., Mangelsdorf D.J., Russell D.W. De-orphanization of cytochrome P450 2R1: A microsomal vitamin D 25-hydroxilase. J. Biol. Chem. 2003, 278:38084-38093.
24. Cheng J.B., Levine M.A., Bell N.H., Mangelsdorf D.J., Russell D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA 2004, 101:7711-7715.
25. Daniel C., Sartory N.A., Zahn N., Radeke H.H., Stein J.M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 2008, 324:23-33.
26. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
27. Ehrchen J., Helming L., Varga G., Pasche B., Loser K., Gunzer M., Sunderkotter C., Sorg C., Roth J., Lengeling A. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J. 2007, 21:3208-3218.
28. Froicu M., Weaver V., Wynn T.A., McDowell M.A., Welsh J.E., Cantorna M.T. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 2003, 17:2386-2392.
29. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., Portale A.A. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 1997, 11:1961-1970.
30. Garlet G.P., Avila-Campos M.J., Milanezi C.M., Ferreira B.R., Silva J.S. Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: Patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect. 2005, 7:738-747.
31. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19:1067-1077.
32. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 2001, 167:1945-1953.
33. Gyetko M.R., Hsu C.H., Wilkinson C.C., Patel S., Young E. Monocyte 1 alpha-hydroxylase regulation: Induction by inflammatory cytokines and suppression by dexamethasone and uremia toxin. J. Leukoc. Biol. 1993, 54:17-22.
34. Gysemans C., van Etten E., Overbergh L., Giulietti A., Eelen G., Waer M., Verstuyf A., Bouillon R., Mathieu C. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 2008, 57:269-275.
35. Hansdottir S., Monick M.M., Hinde S.L., Lovan N., Look D.C., Hunninghake G.W. Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense. J. Immunol. 2008, 181:7090-7099.
36. Henry H.L. Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin. Endocrinology 1985, 116:503-510.
37. Horiuchi N., Suda T., Takahashi H., Shimazawa E., Ogata E. In vivo evidence for the intermediary role of 3',5'-cyclic AMP in parathyroid hormone-induced stimulation of 1alpha,25-dihydroxyvitamin D3 synthesis in rats. Endocrinology 1977, 101:969-974.
38. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., Leung D.Y. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006, 24:341-348.
39. Ichikawa F., Sato K., Nanjo M., Nishii Y., Shinki T., Takahashi N., Suda T. Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1 alpha-hydroxyvitamin D3 into 1 alpha,25-dihydroxyvitamin D3. Bone 1995, 16:129-135.
40. Janulis M., Tembe V., Favus M.J. Role of protein kinase C in parathyroid hormone stimulation of renal 1,25-dihydroxyvitamin D3 secretion. J. Clin. Invest. 1992, 90:2278-2283.
41. Janulis M., Wong M.S., Favus M.J. Structure-function requirements of parathyroid hormone for stimulation of 1,25-dihydroxyvitamin D3 production by rat renal proximal tubules. Endocrinology 1993, 133:713-719.
42. Josien R., Li H.L., Ingulli E., Sarma S., Wong B.R., Vologodskaia M., Steinman R.M., Choi Y. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 2000, 191:495-502.
43. Kato S., Fujiki R., Kim M.S., Kitagawa H. Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J. Steroid Biochem. Mol. Biol. 2007, 103:372-380.
44. Kitanaka S., Takeyama K., Murayama A., Sato T., Okumura K., Nogami M., Hasegawa Y., Niimi H., Yanagisawa J., Tanaka T., Kato S. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N. Engl. J. Med. 1998, 338:653-661.
45. Knip M., Virtanen S.M., Akerblom H.K. Infant feeding and the risk of type 1 diabetes. Am. J. Clin. Nutr. 2010, 91:1506S-1513S.
46. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., Cao W., Wang Y.H., Su B., Nestle F.O., Zal T., Mellman I., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
47. Lehmann B., Querings K., Reichrath J. Vitamin D and skin: New aspects for dermatology. Exp. Dermatol. 2004, 13(Suppl. 4):11-15.
48. Leitersdorf E., Reshef A., Meiner V., Levitzki R., Schwartz S.P., Dann E.J., Berkman N., Cali J.J., Klapholz L., Berginer V.M. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J. Clin. Invest. 1993, 91:2488-2496.
49. Leitersdorf E., Safadi R., Meiner V., Reshef A., Björkhem I., Friedlander Y., Morkos S., Berginer V.M. Cerebrotendinous xanthomatosis in the Israeli Druze: Molecular genetics and phenotypic characteristics. Am. J. Hum. Genet. 1994, 55:907-915.
50. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
51. Liu P.T., Krutzik S.R., Modlin R.L. Therapeutic implications of the TLR and VDR partnership. Trends Mol. Med. 2007, 13:117-124.
52. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179:2060-2063.
53. Loser K., Mehling A., Loeser S., Apelt J., Kuhn A., Grabbe S., Schwarz T., Penninger J.M., Beissert S. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 2006, 12:1372-1379.
54. Mathieu C., Van Etten E., Gysemans C., Decallonne B., Kato S., Laureys J., Depovere J., Valckx D., Verstuyf A., Bouillon R. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner. Res. 2001, 16:2057-2065.
55. O'Kelly J., Hisatake J., Hisatake Y., Bishop J., Norman A., Koeffler H.P. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J. Clin. Invest. 2002, 109:1091-1099.
56. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002, 347:1151-1160.
57. Oppenheim J.J., Tewary P., de la Rosa G., Yang D. Alarmins initiate host defense. Adv. Exp. Med. Biol. 2007, 601:185-194.
58. Pryke A.M., Duggan C., White C.P., Posen S., Mason R.S. Tumor necrosis factor-alpha induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages. J. Cell. Physiol. 1990, 142:652-656.
59. Rajapakse R., Mousli M., Pfaff A.W., Uring-Lambert B., Marcellin L., Bronner C., Jeanblanc M., Villard O., Letscher-Bru V., Klein J.P., Candolfi E. 1, 25-Dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis. J. Steroid Biochem. Mol. Biol. 2005, 96:179-185.
60. Rasmussen H., Wong M., Bikle D., Goodman D.B. Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J. Clin. Invest. 1972, 51:2502-2504.
61. Ren S., Nguyen L., Wu S., Encinas C., Adams J.S., Hewison M. Alternative splicing of vitamin D-24-hydroxylase: A novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J. Biol. Chem. 2005, 280:20604-20611.
62. Rook G.A., Steele J., Fraher L., Barker S., Karmali R., O'Riordan J., Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986, 57:159-163.
63. Rost C.R., Bikle D.D., Kaplan R.A. In vitro stimulation of 25-hydroxycholecalciferol 1alpha-hydroxylation by parathyroid hormone in chick kidney slices: Evidence for a role for adenosine 3',5'-monophosphate. Endocrinology 1981, 108:1002-1006.
64. +-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J. Biol. Chem. 2003, 278:2206-2211.
65. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
66. Schauber J., Gallo R.L. The vitamin D pathway: A new target for control of the skin's immune response?. Exp. Dermatol. 2008, 17:633-639.
67. Schauber J., Dorschner R.A., Coda A.B., Buchau A.S., Liu P.T., Kiken D., Helfrich Y.R., Kang S., Elalieh H.Z., Steinmeyer A., Zugel U., Bikle D.D., et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117:803-811.
68. Schauber J., Oda Y., Buchau A.S., Yun Q.C., Steinmeyer A., Zugel U., Bikle D.D., Gallo R.L. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D(3). J. Invest. Dermatol. 2008, 128:816-824.
69. Schuster I., Egger H., Astecker N., Herzig G., Schussler M., Vorisek G. Selective inhibitors of CYP24: Mechanistic tools to explore vitamin D metabolism in human keratinocytes. Steroids 2001, 66:451-462.
70. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., Takeuchi Y., Fujita T., Fukumoto S., Yamashita T. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. USA 2001, 98:6500-6505.
71. Sigmundsdottir H., Pan J., Debes G.F., Alt C., Habtezion A., Soler D., Butcher E.C. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 2007, 8:285-293.
72. Sly L.M., Lopez M., Nauseef W.M., Reiner N.E. 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 2001, 276:35482-35493.
73. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., Smith K., Gorman D., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 2002, 3:673-680.
74. St-Arnaud R., Messerlian S., Moir J.M., Omdahl J.L., Glorieux F.H. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone Miner. Res. 1997, 12:1552-1559.
75. Stoffels K., Overbergh L., Giulietti A., Verlinden L., Bouillon R., Mathieu C. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J. Bone Miner. Res. 2006, 21:37-47.
76. Topilski I., Flaishon L., Naveh Y., Harmelin A., Levo Y., Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur. J. Immunol. 2004, 34:1068-1076.
77. Ustianowski A., Shaffer R., Collin S., Wilkinson R.J., Davidson R.N. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J. Infect. 2005, 50:432-437.
78. Usui E., Noshiro M., Okuda K. Molecular cloning of cDNA for vitamin D3 25-hydroxylase from rat liver mitochondria. FEBS Lett. 1990, 262:135-138.
79. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J. Steroid Biochem. Mol. Biol. 2005, 97:93-101.
80. Vidal M., Ramana C.V., Dusso A.S. Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription. Mol. Cell. Biol. 2002, 22:2777-2787.
81. Waddington R.J., Moseley R., Embery G. Reactive oxygen species: A potential role in the pathogenesis of periodontal diseases. Oral Dis. 2000, 6:138-151.
82. Wang J.T., Lin C.J., Burridge S.M., Fu G.K., Labuda M., Portale A.A., Miller W.L. Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am. J. Hum. Genet. 1998, 63:1694-1702.
83. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., White J.H. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173:2909-2912.
84. White K.E., Evans W.E., O'Riordan J.L.H., Speer M.C., Econs M.J., Lorenz-Depiereux B., Grabowski M., Meitinger T., Strom T.M. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 2000, 26:345.
85. Wittke A., Weaver V., Mahon B.D., August A., Cantorna M.T. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol. 2004, 173:3432-3436.
86. Wittke A., Chang A., Froicu M., Harandi O.F., Weaver V., August A., Paulson R.F., Cantorna M.T. Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. Arch. Biochem. Biophys. 2007, 460:306-313.
87. Xie Z., Munson S., Huang N., Schuster I., Portale A.A., Miller W.L., Bikle D.D. The mechanism of 1,25-dihydroxyvitamin D3 auto-regulation in keratinocytes. J. Bone Miner. Res. 2001, 16(Suppl. 1):S556.
88. Zasloff M. Sunlight, vitamin D, and the innate immune defenses of the human skin. J. Invest. Dermatol. 2005, 125:xvi-xvii.